Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study

Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study

Abstract Background Management of chronic hepatitis C (CHC) has significantly accelerated in the last few years. Currently, second generation direct acting antivirals (DAAs) promise clearance of infection in most of patients. Here we present the results of the first analysis carried out on data of L...

Full description

Bibliographic Details
Main Authors: Simone Lanini, Paola Scognamiglio, Alessandra Mecozzi, Lorella Lombardozzi, Vincenzo Vullo, Mario Angelico, Antonio Gasbarrini, Gloria Taliani, Adolfo Francesco Attili, Carlo Federico Perno, Adriano De Santis, Vincenzo Puro, Fabio Cerqua, Gianpiero D’Offizi, Adriano Pellicelli, Orlando Armignacco, Francesco Saverio Mennini, Massimo Siciliano, Enrico Girardi, Vincenzo Panella, Giuseppe Ippolito, members of the Lazio Region HCV treatment group
Format: Article
Language:English
Published: BMC 2018-05-01
Series:BMC Infectious Diseases
Subjects:
Hepatitis C virus
Chronic hepatitis C
Liver cirrhosis
Direct acting antiviral
Multicenter cohort study
Mixed effect model
Online Access:http://link.springer.com/article/10.1186/s12879-018-3125-6

Internet

http://link.springer.com/article/10.1186/s12879-018-3125-6

Similar Items